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ABSTRACT
Objective Increasingly, cornea banks are recovering 
donor tissue from pseudophakic donors. Little is known 
about their suitability for Descemet membrane endothelial 
keratoplasty (DMEK) surgery in terms of endothelial cell 
density (ECD) and preparation failure.
Methods and Analysis We explored ECD during donor 
tissue preparation in 2076 grafts. Preparation failure was 
analysed in 1028 grafts used in DMEK surgery at our clinic. 
To monitor ECD and functional results, we matched 86 
DMEK patients who received pseudophakic donor grafts 
with similar recipients of phakic donor grafts and followed 
them up for 36 months.
Results At recovery, mean ECD in pseudophakic donor 
grafts was 2193 cells/mm2 (SD 28.7) and 2364 cells/
mm2 (SD 15.7) in phakic donor grafts (p<0.001). After 
cultivation, the difference increased as pseudophakic 
donor grafts lost 14% of ECD while phakic lost only 6% 
(p<0.001). At transplantation, mean ECD in pseudophakic 
donor grafts was 2272 cells/mm2 (SD 250) and 2370 
cells/mm2 (SD 204) in phakic donor grafts (p<0.001). 
After transplantation, the difference in ECD increased 
as pseudophakic donor grafts lost 27.7% of ECD while 
phakic donor grafts lost only 13.3% (p<0.001). The risk 
of preparation failure in pseudophakic donor grafts was 
higher than in phakic donor grafts (OR 4.75, 95% CI 1.78 
to 12.67, p=0.02). Visual acuity increased in both groups 
similarly.
Conclusions Pseudophakic donor grafts have a lower 
ECD, are more prone to endothelial cell loss during 
recovery and surgery and are associated with a higher risk 
of preparation failure. Cornea banks and surgeons should 
consider this in the planning of graft preparation and 
transplantation.
INTRODUCTION
Descemet membrane endothelial kera-
toplasty (DMEK) has become a standard 
technique to treat corneal endothelial dystro-
phies. Different from other posterior lamellar 
keratoplasty techniques, such as Descemet 
stripping automated endothelial keratoplasty 
(DSAEK), DMEK surgery comprises a trans-
plantation of endothelium and Descemet 
membrane (DM) only.1 The procedure is 
challenging, including the donor tissue 
preparation, but has proven to be superior in 
terms of visual recovery and immunological 
reactions, when compared with DSAEK.2 3 
As such, DMEK has already replaced DSAEK 
as the standard procedure in some parts of 
Europe and the USA.4 5
For a successful surgery, donor tissue 
quality is of importance. Donor tissue with 
high endothelial cell density (ECD), a donor 
age of above 60 years and the absence of 
corneal scars is preferred to assure long- 
term visual recovery, and facilitate donor DM 
preparation.6 7 Many surgeons prefer corneas 
from phakic donors, which mitigate difficul-
ties during preparation as a result of corneal 
scars or adhesions following cataract surgery. 
In addition, tissue from older donors is pref-
erable as unfolding such tissue is often easier 
than in younger donors.8–10 The ideal tissue, 
hence, has a high ECD and comes from an 
older phakic donor.8
Recovering donor tissue form older, phakic 
patients is becoming increasingly difficult. A 
survey conducted in the US population in 
Key messages
What is already known about this subject?
 ► Graft tissue from pseudophakic donors tends to have 
a lower endothelial cell density.
What are the new findings?
 ► Graft tissue from pseudophakic donors is more sus-
ceptible to endothelial cell loss during the cultiva-
tion process and during surgery. Preparation failure 
of donor lamella is more frequent in pseudophakic 
donor grafts. This can lead to a higher rate of pseu-
dophakic donor grafts that are lost or not suitable for 
elective transplantation.
How might these results change the focus of 
research or clinical practice?
 ► Cornea banks and surgeons should consider the dif-
ferences between phakic and pseudophakic donor 
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2004 showed a combined cataract prevalence in the age 
group over 40 years of 17% with rates as high as 50% in 
the age group above 75 years.11 With increased life expec-
tancy, cataract prevalence is expected to rise by 50% in 
the year 2020 and cataract surgery rates are expected to 
rise by over 60%.11 In fact, it has been shown that inci-
dence of cataract surgery has been increasing over the 
past three decades and is unlikely to decline in the near 
future.12 Given these trends, cornea banks will increas-
ingly recover corneas of pseudophakic donors and 
provide them for transplantation.
Even though some DMEK surgeons are already using 
pseudophakic donor tissues,13 little is known about the 
differences between phakic and pseudophakic donor 
tissue. Some reports on DMEK surgeries using pseu-
dophakic donor tissues suggest that ECD is lower than in 
phakic donors but that intraoperative and postoperative 
results are comparable.13 To explore how this difference 
could affect donor tissue preparation and postsur-
gical outcomes, we conducted a retrospective analysis 
of corneal transplants from the moment of recovery to 
3 years after transplantation.
METHODS
We conducted a retrospective analysis that explored 
donor graft tissues used in DMEK surgeries at our clinic 
between 2015 and 2018.
Collection of donor graft data
Collecting donor tissue was conducted by the cornea bank 
of the Charité-Universitätsmedizin Berlin. We reviewed 
donor records of all corneas donated between 2015 and 
2018. Only records that recorded ECD at the beginning 
and after cultivation were included in the analysis.
Recovery of donor graft tissue and cultivation
All donor corneas were obtained by in situ corneo-
scleral disc excision. They were kept in organ culture 
(Minimum Essential Medium with 2% fetal calf serum) 
at 32°C±1°C. The ECD was estimated at the start of 
organ culture and 24±6 hours after transfer to dextran- 
containing deswelling medium prior release for 
transplantation, using at least two digital 200× images 
from an inverse phase contrast microscope (Olympus 
CK 40, Olympus, Hamburg, Germany) postosmotic stim-
ulation with hypotonic balanced salt solution. The ECD 
was estimated using a fixed frame of maximum possible 
size with manual marking of the cells with the NAVIS cell 
counting software (Nidek Technologies, Padova, Italy). 
All measurements of ECD were done at the centre of the 
cornea. Morphological parameters (polymegatism, pleo-
morphism, vacuolisation and granulation) were assessed 
visually during endothelial cell microscopy and graded 
as no changes, mild changes or severe changes. Only 
corneas with no or mild changes were released for trans-
plantation and included in this study.
Collection of recipient data
From the transplantation records we identified all grafts 
that were used at our clinic for DMEK surgery. The 
recipient case files were reviewed to identify DMEK 
patients without ocular comorbidities that could compli-
cate the surgery or would lead to a reduced prognosis. 
We included phakic and pseudophakic patients with 
Fuchs endothelial dystrophy (FED), bullous keratopathy 
or first graft failure without a history of ocular surgeries 
(except cataract surgery). We also excluded all patients 
with a history of uveitis and uncontrolled glaucoma and 
patients who did not attend follow- up visits at our clinic. 
Based on these criteria, we identified suitable recipients 
of pseudophakic donor graft tissue and matched them to 
recipients of phakic donor graft tissue. We used possible 
confounders with an effect on ECD as matching criteria 
and matched on type of surgery, use of antiglaucoma 
eye- drops, history of diabetes and age (with a range of 
5 years).
Surgical procedure and follow-up
All patients underwent DMEK surgery at out clinic with the 
same experienced surgeon (NT). In brief, after removal 
of the host’s DM, the graft was injected into the ante-
rior chamber. After unfolding of the graft, the anterior 
chamber was filled with air aiming at a physiological or 
slightly elevated pressure. No iridotomy or iridectomy was 
performed. We partially removed the air 2 hours after the 
surgery. The donor tissue DM was prepared by the same 
surgeon directly prior to transplantation. The DM was 
dissected with a scraping technique from the periphery, 
gently teared with blunt forceps and punched centrally 
with a trephine of desired size (approximately 8.5 mm 
diameter). Standard postoperative topical treatment 
included steroids, antibiotics and lubricant eye- drops. 
Patients were followed up for 3 years. At each examina-
tion we tested best corrected visual acuity (BCVA) with 
a Snellen chart, performed a slit lamp examination and 
an optical coherence tomography (OCT) examination of 
the cornea using a Spectralis OCT device with an anterior 
chamber attachment (Spectralis OCT, Heidelberg Engi-
neering Family Acquisition Module 5.3.3.0, Heidelberg 
Engineering Viewing Module 5.3.2.0 and Heidelberg 
Eye Explorer 1.6.4.0 software, Heidelberg Engineering, 
Heidelberg, Germany). The Snellen decimal number 
was converted in logMAR visual acuity using a conver-
sion table. ECD was measured at the centre of the cornea 
using the specular microscope Nidek CEM-530 (NIDEK, 
Japan).
Statistical analysis
All data were entered into a database and checked for 
errors. We used STATA V.12.1 (StataCorp, College Station, 
Texas, USA) for statistical analysis and graphs were drawn 
using the ggplot2 module in R- statistics. Bivariable associ-
ations were tested using a χ2 or t- test, where appropriate.
For binary outcomes, we used a logistic regression 
model controlling for confounders. To model ECD 
over time, we used a mixed effects regression model 
controlling for repeated observations per individual 
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the difference in the rate of endothelial cell loss (ECL), 
we measured the difference in the rate of ECL between 
pseudophakic and phakic donor tissues, controlling for 
confounders. With this approach, a difference of 0 would 
indicate that there is no difference in the rate of ECL 
between the two groups. This approach allows to explore 
the effect of donor lens status on ECD while controlling 
for baseline differences (such as donor age) between the 
two groups. We assumed a significance level of 0.05 and 
used a Bonferroni correction to account for multiple 
testing.
For the statistical analysis of BCVA, we excluded all 
patients with extracorneal limitations such as age- related 
macular degeneration or amblyopia.
Patient and public involvement
There was no patient involvement in planning and 
executing this study. We are planning to inform future 
patients when planning DMEK surgeries and the public 




Between January 2015 and January 2018, we reviewed 
protocols of 3077 donor corneas. As ECD estimation at 
the beginning of organ culture is not always possible, we 
identified 2076 donor cornea protocols with complete 
ECD data. Of these, 392 (18.9%) were from pseu-
dophakic donors.
Pseudophakic donors were older than phakic donors 
and there were a higher number of female donors 
(table 1). At recovery, pseudophakic donor grafts showed 
a lower ECD than phakic donor grafts (table 1). In both 
groups, ECD decreased after cultivation but ECL was 
higher in the pseudophakic group (table 1). In the pseu-
dophakic group ECL was 14% while in the phakic group 
ECL was only 6%. Controlling for donor age and culti-
vation time, the rate of ECL was 105 cells (95% CI 56 to 
153, p<0.001) higher in pseudophakic donor grafts than 
in the phakic donor grafts. This resulted in an increase in 
the mean difference in ECD between pseudophakic and 
phakic donor grafts (table 1). The lower ECD at recovery 
and the higher rate of ECL during cultivation meant that 
196 (50%) of the pseudophakic donor corneas did not 
meet the minimum quality criteria for an elective graft 
(>2000 cells/mm2). In the phakic donor group, only 
218 (13%) did not reach a minimum of 2000 cells/mm2 
(p<0.001).
Post-transplantation
Of all recovered donor grafts, 1028 were used at our 
clinic for DMEK surgery. The remaining ones were either 
of too low ECD for an elective procedure, sent to other 
clinics for grafting or they were used in penetrating kera-
toplasty. The 1028 grafts included 126 pseudophakic 
donor grafts. Seven pseudophakic donor grafts were 
lost during preparation, and of the remaining 119 pseu-
dophakic donor grafts, 33 had to be excluded as either 
the recipient did not meet with our inclusion criteria or 
they did not complete follow- up visits at our clinic.
Donor preparation
Preparation of donor grafts failed in 7 (5.6%) of the 126 
pseudophakic donor grafts and in 17 (1.9%) of the 902 
phakic donor grafts (p=0.011). Controlling for the donor 
age and cultivation time, we found that the risk of prepa-
ration failure was almost five times higher (OR 4.75, 95% 
CI 1.78 to 12.67, p=0.02) in pseudophakic donor grafts 
than in phakic donor grafts. Smaller tears occurred in 
10 (7.9%) of the pseudophakic donor grafts and in 55 
(6.1%) of the phakic donor grafts (p=0.476).
Endothelial cell density
Matching the recipients of pseudophakic donor grafts 
with recipients of phakic donor grafts resulted in 
balanced groups (table 2). At surgery, the average ECD 
in the pseudophakic donor group was lower than in the 
phakic donor group (table 2, figure 1). At 3 months after 
surgery, the drop in ECD was higher in the pseudophakic 
group than in the phakic group (figure 1, table 3). When 
controlling for confounder (donor age and cultivation 
time), the rate of ECL was 301 cells/mm2 (95% CI 106 to 
497, p=0.003) higher in the pseudophakic donor grafts 
than in the phakic grafts. This meant that the difference 
in ECD between both groups increased (table 3). Beyond 
Table 1 Characteristics of 2076 donors tissues
Pseudophakic donors (n=392) Phakic donors (n=1684)
Mean (SD) n (%) Mean (SD) n (%)
Age (years) 86.8 (0.276) 78.3 (0.35)
Female 196 (50) 645 (38)
ECD at recovery (cells/mm2) 2193 (28.7) 2364 (15.7)
ECD after cultivation (cells/mm2) 1878 (17.3) 2213 (8.37)
Cultivation time (days) 16.2 (0.09) 16.21 (0.21)
Postmortem time (hours) 29.8 (12.7) 29.9 (12.6)
Difference in ECD between before and after cultivation (cells/mm2) 315 (14.3%) 151 (6.3%)
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3 months after surgery, no major differences in the rate 
of ECL were observed and ECD decreased at a similar 
rate between the two groups over the 36- month observa-
tion period (figure 1, table 3).
BCVA and central corneal thickness
A significant postoperative increase in visual acuity 
was noted in both groups (p<0.001) with no differ-
ence between pseudophakic and phakic donor grafts 
(figure 1). The increase was highest up until 3 months 
after surgery, thereafter only minor changes in visual 
acuity were noted. The increase in BCVA remained stable 
throughout the study period. Similarly, central corneal 
thickness (CCT) dropped strongly up until 6 months after 
surgery (p<0.001) without any differences between both 
groups (figure 1). As of 12 months after surgery, a slight 
increase in CCT was noted in both groups (figure 1).
Complication rates
No relevant intraoperative complications were noted. 
Surgery time was comparable between both groups 
(data not shown). All DMEK surgeries were performed 
according to our standard procedure and by the same 
surgeon (NT)
In the pseudophakic group 26 cases (30%) required a 
rebubbling, whereas in the phakic group 16 cases (19%) 
required rebubbling (p=0.08). A second rebubbling 
was needed in four cases (4.6%) of the pseudophakic 
donor grafts and in three cases (3.5%) of the phakic 
grafts (p=0.711). When controlling for donor age, pseu-
dophakic donor grafts were not associated with a higher 
risk of graft detachment (p=0.536).
Primary graft failures were observed in one case in each 
group. These were successfully treated with a re- DMEK. 
Immune reactions were seen in three patients (3.5%) in 
the pseudophakic group and in two patients (2.3%) in 
the phakic group. All cases resolved during the course of 
follow- up.
DISCUSSION
Grafts of pseudophakic donors have a lower initial ECD 
than grafts from phakic donors and they lose ECD quicker 
during cultivation and surgery. The lower ECD, however, 
does not affect the mid- term postoperative outcomes.
The lower ECD of pseudophakic donor grafts was 
consistent over the entire study period. Prior to surgery, 
pseudophakic donor grafts showed a lower ECD at 
recovery, and these grafts lost a higher number of endo-
thelial cells during cultivation. Further investigation 
should therefore also focus on changes of endothelial 
cell morphology and endothelial cell necrosis during 
and prior to cultivation. This could be done using a 
systematic approach described by Feizi et al14 who used 
a grading based on morphological criteria to explore 
the effect of donor features on postsurgical outcomes in 
patients undergoing deep anterior lamellar keratoplasty. 
Although Feizi et al14 did not find that morphological 
criteria were associated with worse postsurgical outcomes 
they might be correlated with the amount of ECL.
The higher loss in ECD in the pseudophakic group 
was independent of donor age and cultivation time. This 
suggests that prior exposure to cataract surgery renders 
donor grafts more susceptible to ECL during cultivation. 
Table 2 Baseline characteristics of DMEK recipients stratified by donor lens status
Pseudophakic donors (n=86) Phakic donors (n=85) P value
Mean (SD) n (%) Mean (SD) n (%)
Age (years) 74.4 (9.1) 72.8 (8.7) 0.101
Female 55 (64.0) 57 (67.1) 0.669
Reason for DMEK
  FED 77 (89.5) 79 (92.9) 0.658
  Bullous keratopathy 7 (8.1) 4 (4.7)
  Graft failure 2 (2.4) 2 (2.4)
Type of DMEK
  DMEK 46 (53.5) 46 (54.1) 0.996
  Re- DMEK 2 (2.4) 2 (2.4)
  Triple DMEK 38 (44.2) 37 (43.6)
Donor tissue at surgery
  Age (years) 77.5 (9.1)   67.2 (11.2)   <0.001
  Female   45 (52.2)   35 (41.2) 0.182
  ECD (cells/mm2) 2272 (250)   2370 (204)   0.007
  Cultivation time (days) 16.2 (4.1)   15.1 (3.1)   0.082
  Postmortem time (hours) 29.4 (11.4) 29.4 (13.8) 0.987
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We found that after cultivation, the average pseudophakic 
donor cornea was below the quality cut- off for an elective 
graft (at this clinic 2000 cells/mm2) whereas the average 
phakic donor exceeded it considerably. In fact, the rate 
of corneas with insufficient ECD was almost four times 
higher in the pseudophakic group than in the phakic 
group. This could mean that with a higher number of 
pseudophakic donors, cornea banks will have to increase 
the number of corneas recovered to achieve an equal 
number of high- quality corneas.
Figure 1 Endothelial cell density (A), corneal thickness (B), and best corrected visual acuity (BCVA) (C) in recipients of phakic 
and pseudophakic donor grafts from surgery to 3 years after surgery.
Table 3 Mean endothelial cell loss and mean difference in endothelial cell density in cells/mm2 between pseudophakic and 
phakic donors after surgery
Mean ECL compared with at surgery (%) Mean difference in ECD (95% CI)
Pseudophakic Phakic
At surgery 97 (26 to 176)
  3 months 631 (27.7) 315 (13.3) 393 (253 to 533)
  6 months 646 (28.4) 393 (16.6) 393 (223 to 563)
  12 months 747 (32.8) 468 (19.7) 286 (124 to 412)
  24 months 930 (40.9) 547 (23.1) 384 (214 to 554)
  36 months 1186 (52.2) 761 (32.1) 438 (12 to 864)
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Besides an adequate ECD, suitability for graft lamella 
preparation is an additional aspect in DMEK surgery. 
Here we found that pseudophakic donor grafts were 
associated with a higher risk of preparation failure. This 
observation is different from a study by Schaub et al.13 
who noted no preparation failures. Although we were 
unable to access the medical history of the donor for 
this retrospective study to account for diabetes status 
of the donor, a risk factor for preparation failure,15 we 
did control for complicating factors such as donor age 
and cultivation time.6 16 The higher rate of preparation 
failure suggests that adhesions following cataract surgery 
may contribute to complicating the preparation of pseu-
dophakic donor tissue. New preparation techniques, as 
have been suggested for diabetic donor tissue,17 may help 
reduce preparation failure rates.
Although only corneas with an ECD ≥2000 cells/mm2 
were transplanted, donor grafts from pseudophakic and 
phakic donors are not of the same quality. Consistent 
with previous studies,13 pseudophakic donor grafts have 
a lower ECD than phakic donor grafts at surgery. It has 
been suggested that donor age affects ECD negatively,8 
but in our analysis the difference in ECD was indepen-
dent of age and cultivation time. Similarly, Schaub et 
al.13 did not find an effect of donor age on ECD but they 
observed a strong effect of donor lens status. In addi-
tion, we show that immediately after surgery, but not 
during the remaining observation period, ECD drops 
considerably faster in pseudophakic donor grafts than 
in phakic grafts. This difference was not explained by 
possible confounders included in this study and could 
indicate that grafts from pseudophakic donors are 
more prone to ECL during surgery than grafts of phakic 
donors.
ECL can be influenced by many factors. In this study 
we had limited information on donor characteristics 
that could have affected ECD. Although some evidence 
suggests that a systemic disease such as diabetes does not 
affect ECD of donor grafts,15 this effect could be different 
for other diseases. We could not explore such effects 
and hence our interpretation is limited. On the other 
hand, postmortem time, cultivation time and donor age 
have been suggested to negatively affect ECD7 and were 
controlled for in our analysis. In addition, some studies 
suggest that recipient characteristics may be of greater 
importance for postoperative outcomes.15 We matched 
on known confounders such as age and diabetes and also 
included unknown ones such as use of antiglaucoma eye- 
drops.
Despite the difference in ECD, BCVA and CCT did 
not differ between pseudophakic and phakic donor 
grafts. This observation is similar to findings produced 
by Schaub et al.13 who suggest that resolution of corneal 
oedema may be faster in phakic donor grafts but that 
visual acuity is similar in both groups. Here we found 
almost no difference in the resolution of corneal oedema 
or increase in visual acuity. This indicates that although 
ECD differs between the two groups, up to 3 years after 
surgery, ECD levels in both groups are high enough to 
assure normal function.
Graft detachment is a frequent complication in DMEK 
surgery. To date, little is known about donor charac-
teristic that could affect graft detachment. While some 
studies suggest that younger donor age is associated with 
a higher rebubbling rate,7 others indicate the opposite.10 
It has been suggested that grafts from pseudophakic 
donors are more fragile or stiffer and could therefore be 
more prone to graft detachment.13 In this study, however, 
we did not find evidence for an effect of donor lens status 
on graft detachment.
In conclusion, pseudophakic donor grafts have a lower 
ECD and are more prone to ECL during cultivation and 
surgery. If recovering pseudophakic donor grafts becomes 
more common, cornea banks may have to increase their 
recovery rate in order to compensate for the lower 
quality of the grafts. In addition, surgeons should take 
special care when handling pseudophakic donor tissue 
as the risk of preparation failure can be higher than in 
phakic donor grafts. Although functional results of both 
grafts are comparable, long- term follow- ups are needed 
to compare the rate of graft failure between recipients of 
pseudophakic and phakic donor grafts.
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